Keywords: Male breast cancer; Androgen receptor; Androgens; Anti-androgen therapy; Gonadotropin-releasing hormone analogsAIs, aromatase inhibitors; AR, androgen receptor; BC, breast cancer; CPA, cyproterone acetate; ER, estrogen receptor; FBC, female breast cancer;